InnovAge Holding Corp. (NASDAQ:INNV) Q4 2023 Earnings Call Transcript

Page 5 of 5

Patrick Blair: Thank you for your continued interest in the company. We are excited to be unencumbered by the sanctions, we worked hard to address those in the last fiscal year. We’re growing our top line consistent with historical standards. We’re getting reasonably good rates from our states and CMS and improving risk adjustment. We have some de novos that are coming online and with more in later years. And we’re really pleased with our progress. I think I would sum it up is, it’s a question of not when or should be, not if, but when. We’re really confident in the profile of the company going forward. It’s just a question of timing on a lot of fronts. And that’s what we’re doing our best to predict each quarter and we look forward to bringing folks into our Investor Day sometime after second quarter and we’ll will take people through the drivers of the business. So really appreciate everyone’s support and look forward to the future.

Operator: Thank you all for participating. This concludes today’s program. You may now disconnect.

Follow Innovus Pharmaceuticals Inc. (OTCMKTS:INNV)

Page 5 of 5